Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chin B Eap

Showing results (151-160 of 179) with videos related to

Pageof 18
Sort By:
Nutrition & Metabolism|November 29, 2016
Relation of 24-hour urinary caffeine and caffeine metabolite excretions with self-reported consumption of coffee and other caffeinated beverages in the general populationDusan Petrovic, Sandrine Estoppey Younes, Menno Pruijm, et al.
Journal of Clinical Psychopharmacology|August 18, 2015
Association of PCK1 with Body Mass Index and Other Metabolic Features in Patients With Psychotropic TreatmentsNúria Saigi-Morgui, Frederik Vandenberghe, Aurélie Delacrétaz, et al.
Plos One|October 14, 2015
Influence of MCHR2 and MCHR2-AS1 Genetic Polymorphisms on Body Mass Index in Psychiatric Patients and In Population-Based Subjects with Present or Past Atypical DepressionAurélie Delacrétaz, Martin Preisig, Frederik Vandenberghe, et al.
Pharmacogenetics and Genomics|March 10, 2015
Impact of HSD11B1 polymorphisms on BMI and components of the metabolic syndrome in patients receiving psychotropic treatmentsLina Quteineh, Frederik Vandenberghe, Nuria Saigi Morgui, et al.
Lancet (London, England)|January 26, 2002
Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics studyJacques Fellay, Catia Marzolini, Emma R Meaden, et al.
Frontiers in Psychiatry|January 6, 2022
Associations Between High Plasma Methylxanthine Levels, Sleep Disorders and Polygenic Risk Scores of Caffeine Consumption or Sleep Duration in a Swiss Psychiatric CohortNermine Laaboub, Mehdi Gholam, Guibet Sibailly, et al.
Plos One|October 28, 2016
Weighted Genetic Risk Scores and Prediction of Weight Gain in Solid Organ Transplant PopulationsNúria Saigi-Morgui, Lina Quteineh, Pierre-Yves Bochud, et al.
BMC Psychiatry|May 17, 2022
Insomnia disorders are associated with increased cardiometabolic disturbances and death risks from cardiovascular diseases in psychiatric patients treated with weight-gain-inducing psychotropic drugs: results from a Swiss cohortNermine Laaboub, Céline Dubath, Setareh Ranjbar, et al.
Frontiers in Psychiatry|June 5, 2023
Infant exposure to Fluvoxamine through placenta and human milk: a case series - A contribution from the ConcePTION projectAnaëlle Monfort, Evelina Cardoso, Chin B Eap, et al.
Hypertension (Dallas, Tex. : 1979)|December 10, 2014
Associations of ambulatory blood pressure with urinary caffeine and caffeine metabolite excretionsIdris Guessous, Menno Pruijm, Belén Ponte, et al.
Pageof 18

Showing results (151-160 of 179) with videos related to

Sort By:
Pageof 18
Nutrition & Metabolism|November 29, 2016
Relation of 24-hour urinary caffeine and caffeine metabolite excretions with self-reported consumption of coffee and other caffeinated beverages in the general populationDusan Petrovic, Sandrine Estoppey Younes, Menno Pruijm, et al.
Journal of Clinical Psychopharmacology|August 18, 2015
Association of PCK1 with Body Mass Index and Other Metabolic Features in Patients With Psychotropic TreatmentsNúria Saigi-Morgui, Frederik Vandenberghe, Aurélie Delacrétaz, et al.
Plos One|October 14, 2015
Influence of MCHR2 and MCHR2-AS1 Genetic Polymorphisms on Body Mass Index in Psychiatric Patients and In Population-Based Subjects with Present or Past Atypical DepressionAurélie Delacrétaz, Martin Preisig, Frederik Vandenberghe, et al.
Pharmacogenetics and Genomics|March 10, 2015
Impact of HSD11B1 polymorphisms on BMI and components of the metabolic syndrome in patients receiving psychotropic treatmentsLina Quteineh, Frederik Vandenberghe, Nuria Saigi Morgui, et al.
Lancet (London, England)|January 26, 2002
Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics studyJacques Fellay, Catia Marzolini, Emma R Meaden, et al.
Frontiers in Psychiatry|January 6, 2022
Associations Between High Plasma Methylxanthine Levels, Sleep Disorders and Polygenic Risk Scores of Caffeine Consumption or Sleep Duration in a Swiss Psychiatric CohortNermine Laaboub, Mehdi Gholam, Guibet Sibailly, et al.
Plos One|October 28, 2016
Weighted Genetic Risk Scores and Prediction of Weight Gain in Solid Organ Transplant PopulationsNúria Saigi-Morgui, Lina Quteineh, Pierre-Yves Bochud, et al.
BMC Psychiatry|May 17, 2022
Insomnia disorders are associated with increased cardiometabolic disturbances and death risks from cardiovascular diseases in psychiatric patients treated with weight-gain-inducing psychotropic drugs: results from a Swiss cohortNermine Laaboub, Céline Dubath, Setareh Ranjbar, et al.
Frontiers in Psychiatry|June 5, 2023
Infant exposure to Fluvoxamine through placenta and human milk: a case series - A contribution from the ConcePTION projectAnaëlle Monfort, Evelina Cardoso, Chin B Eap, et al.
Hypertension (Dallas, Tex. : 1979)|December 10, 2014
Associations of ambulatory blood pressure with urinary caffeine and caffeine metabolite excretionsIdris Guessous, Menno Pruijm, Belén Ponte, et al.
Pageof 18